CompaniesArbor Biotechnologies

Arbor Biotechnologies

active

Cambridge, MA, United States

Founded 2016

About

CRISPR enzymes

Areas of Focus

Categories

Boston & New England

Team (8)

Dan Ory, M.D.Chief Medical Officer

Arbor Biotechnologies

Devyn Smith, Ph.D.

Devyn Smith, Ph.D.Chief Executive Officer

Arbor Biotechnologies

Don Haut, Ph.D., MBA

Don Haut, Ph.D., MBAChief Business Officer

Arbor Biotechnologies

Iya Kessler, J.D.

Iya Kessler, J.D.General Counsel and Corporate Secretary

Arbor Biotechnologies

John Murphy, Ph.D.

John Murphy, Ph.D.Chief Scientific Officer

Arbor Biotechnologies

Lee Ann Marchionna, MBA

Lee Ann Marchionna, MBAChief People Officer

Arbor Biotechnologies

View all 8 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

23

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

2036

2037

2038

2039

2040

2041

2042

2043

2044

Today

Hover over trial bars to see details

Recent Trials

NCT06839235Lead Sponsor

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

PHASE1/PHASE2Recruiting

23 participants

Started: Jun 16, 2025 · Completed: Feb 28, 2043

Funding History (3)

D

Nov 10, 2021

D/A

Aug 2, 2017

D

Jun 1, 2017

Locations (1)

Headquarters

Cambridge, MA, United States

Map

Loading map...

Arbor Biotechnologies | Biotech Hunter | Biotech Hunter